Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Makerere University
Information provided by (Responsible Party):
Tuberculosis Clinical Diagnostics Research Consortium
ClinicalTrials.gov Identifier:
NCT01525134
First received: January 20, 2012
Last updated: February 1, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2012
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):